临床和实验医学杂志
臨床和實驗醫學雜誌
림상화실험의학잡지
JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
2015年
11期
883-887
,共5页
子宫内膜样腺癌%子宫内膜增生%孕激素%病理检查
子宮內膜樣腺癌%子宮內膜增生%孕激素%病理檢查
자궁내막양선암%자궁내막증생%잉격소%병리검사
Endometrial adenocarcinoma%Endometrial hyperplasia%Progesterone%Pathological examination
目的观察孕激素治疗Ia期子宫内膜样腺癌及内膜复杂性不典型增生患者的临床病理和预后。方法对15例Ia期子宫内膜样腺癌患者及25例子宫内膜复杂性不典型增生患者应用孕激素治疗,并对其治疗效果进行比较。结果治疗后,复杂性不典型增生有效率(22/25,88.0%)高于子宫内膜癌(13/15,86.7%),但差异无统计学意义( P >0.05)。完全有效的内膜癌患者8例中有3例复发,中位复发时间9月(6~48个月);20例癌前病变完全有效的复杂性不典型增生患者8例复发,中位复发12个月(6~52个月)。28例癌及癌前病变完全有效的患者有12例进行了3个月至半年的巩固治疗,但出现4例复发;18例未行巩固治疗,有7例复发。内膜癌患者治疗后5例正常妊娠,复杂不典型增生患者治疗后12例正常妊娠。对孕激素的反应表现为腺体狭小、萎缩、内膜间质水肿或蜕膜化;腺上皮单层胞质较为丰富,细胞核萎缩。结论 Ia期子宫腺癌及复杂性不典型增生的孕激素治疗效果良好,但进程缓慢、复发率较高,复发患者可再次使用孕激素治疗。
目的觀察孕激素治療Ia期子宮內膜樣腺癌及內膜複雜性不典型增生患者的臨床病理和預後。方法對15例Ia期子宮內膜樣腺癌患者及25例子宮內膜複雜性不典型增生患者應用孕激素治療,併對其治療效果進行比較。結果治療後,複雜性不典型增生有效率(22/25,88.0%)高于子宮內膜癌(13/15,86.7%),但差異無統計學意義( P >0.05)。完全有效的內膜癌患者8例中有3例複髮,中位複髮時間9月(6~48箇月);20例癌前病變完全有效的複雜性不典型增生患者8例複髮,中位複髮12箇月(6~52箇月)。28例癌及癌前病變完全有效的患者有12例進行瞭3箇月至半年的鞏固治療,但齣現4例複髮;18例未行鞏固治療,有7例複髮。內膜癌患者治療後5例正常妊娠,複雜不典型增生患者治療後12例正常妊娠。對孕激素的反應錶現為腺體狹小、萎縮、內膜間質水腫或蛻膜化;腺上皮單層胞質較為豐富,細胞覈萎縮。結論 Ia期子宮腺癌及複雜性不典型增生的孕激素治療效果良好,但進程緩慢、複髮率較高,複髮患者可再次使用孕激素治療。
목적관찰잉격소치료Ia기자궁내막양선암급내막복잡성불전형증생환자적림상병리화예후。방법대15례Ia기자궁내막양선암환자급25례자궁내막복잡성불전형증생환자응용잉격소치료,병대기치료효과진행비교。결과치료후,복잡성불전형증생유효솔(22/25,88.0%)고우자궁내막암(13/15,86.7%),단차이무통계학의의( P >0.05)。완전유효적내막암환자8례중유3례복발,중위복발시간9월(6~48개월);20례암전병변완전유효적복잡성불전형증생환자8례복발,중위복발12개월(6~52개월)。28례암급암전병변완전유효적환자유12례진행료3개월지반년적공고치료,단출현4례복발;18례미행공고치료,유7례복발。내막암환자치료후5례정상임신,복잡불전형증생환자치료후12례정상임신。대잉격소적반응표현위선체협소、위축、내막간질수종혹세막화;선상피단층포질교위봉부,세포핵위축。결론 Ia기자궁선암급복잡성불전형증생적잉격소치료효과량호,단진정완만、복발솔교고,복발환자가재차사용잉격소치료。
Objective To observe the clinical pathology and prognosis of Ia stage endometroid adenocarcinoma( EAC)patients and endo-metrial complex atypical hyperplasia( ECAH)patients after progestogen treatment. Methods A total of 15 Ia stage EAC patients and 25 ECAH patients admitted to our hospital were selected as the subjects,who all received progestogen treatment. The effectiveness of treatment was com-pared. Results After accepted with progesterone treatment,total effective rate of ECAH grou(88. 0%)was higher than primary EAC group(86. 7%)( P >0. 05). Among the 8 cases showing complete response,3 cases showed recurrence,and the median recurrence time was 9 months(6~48 months);among the 20 cases of ECAH showing complete response,8 cases showed recurrence,and the median recurrence time was 12 months(6~52 months). Among the 28 cases showing complete response,12 cases received 3 months to half year of consolidation treatment,but 4 cases showed recurrence;18 cases did not receive consolidation treatment,and 7 cases showed recurrence. After treatment,5 cases of EAC and 12 cases of ECAH had normal pregnancy. The responses to progestogen were gland narrowness,atrophy,endometrial interstitial edema or decidual-ization;abundant cytoplasm of glandular epithelium monolayer and nuclear atrophy. Conclusion The progestogen treatment has good effects on Ia stage EAC and ECAH,but the course is slow and the recurrence rate is high. The progestogen treatment can be used again for recurrence.